Covid-19 vaccine production
Ended Definitive Contract Awarded Last action
- Contract number
- W15QKN21C0012
- Awardee
-
Pfizer Inc. UEI MHBQULRMEEJ5
- Awarding agency
-
ACC Picatinny
Army Contracting Command, Department of Defense
- Obligated
- $33,330,402,197
Award facts
- Opportunity
-
- W15QKN21R0038 Solicitation number
- Pfizer COVID 19 Vaccine Limited / Sole Source Justification · Posted Jan 25, 2021
- Production of COVID-19 BNT162b2 Vaccine Award Notice · Posted Dec 23, 2020
- Contract value 295% obligated
-
- $11,110,134,065.68 Current, with exercised options
- $11,285,134,065.68 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- New York, NY 10017, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$30 | |
| Funding Only Action | -$30 | |
| Funding Only Action | -$30 | |
| Supplemental Agreement for work within scope | -$33,834,849 | |
| Supplemental Agreement for work within scope | -$33,834,849 | |
| Supplemental Agreement for work within scope | -$33,834,849 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$10,000,000 | |
| Supplemental Agreement for work within scope | -$10,000,000 | |
| Supplemental Agreement for work within scope | -$10,000,000 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $29,890,708 | |
| Supplemental Agreement for work within scope | $29,890,708 | |
| Supplemental Agreement for work within scope | $29,890,708 | |
| Supplemental Agreement for work within scope | -$1,883,263 | |
| Supplemental Agreement for work within scope | -$1,883,263 | |
| Supplemental Agreement for work within scope | -$1,883,263 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $0 | |
| Funding Only Action | $0 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $80,400,000 | |
| Supplemental Agreement for work within scope | $80,400,000 | |
| Supplemental Agreement for work within scope | $80,400,000 | |
| Exercise an Option | $1,230,000,000 | |
| Exercise an Option | $1,230,000,000 | |
| Exercise an Option | $1,230,000,000 | |
| Funding Only Action | $0 | |
| Funding Only Action | $0 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $902,125,000 | |
| Supplemental Agreement for work within scope | $902,125,000 | |
| Supplemental Agreement for work within scope | $902,125,000 | |
| Supplemental Agreement for work within scope | -$41,000,000 | |
| Supplemental Agreement for work within scope | -$41,000,000 | |
| Supplemental Agreement for work within scope | -$41,000,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 |
Show 40 more
Latest 50 listed here. See the rest on GovTribe.
About this award
The Department of Defense's Joint PEO Chemical and Biological Defense awarded a definitive contract to Pfizer Inc. for COVID-19 vaccine production on December 22, 2020, with a ceiling value of $11.285 billion and an ultimate completion date of June 30, 2023. No set-aside was used. This award is now deobligation in support of closeout.
Place of performance is New York, NY. The contract is priced on a firm fixed price basis.
Quick answers
Who was awarded contract W15QKN21C0012?
W15QKN21C0012 was awarded to Pfizer Inc. by ACC Picatinny (Army Contracting Command) on December 22, 2020.
How much is contract W15QKN21C0012 worth?
The government has obligated $33,330,402,197 on W15QKN21C0012. Its current value, with exercised options, is $11,110,134,066. Its potential value, with all options, is $11,285,134,066.
Which agency awarded contract W15QKN21C0012?
ACC Picatinny (Army Contracting Command) awarded W15QKN21C0012, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).
Was contract W15QKN21C0012 competed?
The extent of competition for W15QKN21C0012 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award